177 related articles for article (PubMed ID: 17203009)
1. Mechanisms of Disease: the role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis.
Jiang W; Pisetsky DS
Nat Clin Pract Rheumatol; 2007 Jan; 3(1):52-8. PubMed ID: 17203009
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis.
Ostberg T; Wähämaa H; Palmblad K; Ito N; Stridh P; Shoshan M; Lotze MT; Harris HE; Andersson U
Arthritis Res Ther; 2008; 10(1):R1. PubMed ID: 18179697
[TBL] [Abstract][Full Text] [Related]
3. The cytokine activity of HMGB1--extracellular escape of the nuclear protein.
Sun NK; Chao CC
Chang Gung Med J; 2005 Oct; 28(10):673-82. PubMed ID: 16382751
[TBL] [Abstract][Full Text] [Related]
4. The cytokine activity of HMGB1.
Yang H; Wang H; Czura CJ; Tracey KJ
J Leukoc Biol; 2005 Jul; 78(1):1-8. PubMed ID: 15734795
[TBL] [Abstract][Full Text] [Related]
5. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
Voll RE; Urbonaviciute V; Herrmann M; Kalden JR
Isr Med Assoc J; 2008 Jan; 10(1):26-8. PubMed ID: 18300566
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group box 1 (HMGB1) protein: friend and foe.
Ulloa L; Messmer D
Cytokine Growth Factor Rev; 2006 Jun; 17(3):189-201. PubMed ID: 16513409
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis.
Andersson U; Tracey KJ
Rheum Dis Clin North Am; 2004 Aug; 30(3):627-37, xi. PubMed ID: 15261345
[TBL] [Abstract][Full Text] [Related]
8. The gesture life of high mobility group box 1.
Friedman SG; Czura CJ; Tracey KJ
Curr Opin Clin Nutr Metab Care; 2003 May; 6(3):283-7. PubMed ID: 12690260
[TBL] [Abstract][Full Text] [Related]
9. Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis.
Palmblad K; Sundberg E; Diez M; Söderling R; Aveberger AC; Andersson U; Harris HE
Arthritis Res Ther; 2007; 9(2):R35. PubMed ID: 17397533
[TBL] [Abstract][Full Text] [Related]
10. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo.
Faraco G; Fossati S; Bianchi ME; Patrone M; Pedrazzi M; Sparatore B; Moroni F; Chiarugi A
J Neurochem; 2007 Oct; 103(2):590-603. PubMed ID: 17666052
[TBL] [Abstract][Full Text] [Related]
11. Relevance of high-mobility group protein box 1 to neurodegeneration.
Fossati S; Chiarugi A
Int Rev Neurobiol; 2007; 82():137-48. PubMed ID: 17678959
[TBL] [Abstract][Full Text] [Related]
12. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
Mbalaviele G; Sommers CD; Bonar SL; Mathialagan S; Schindler JF; Guzova JA; Shaffer AF; Melton MA; Christine LJ; Tripp CS; Chiang PC; Thompson DC; Hu Y; Kishore N
J Pharmacol Exp Ther; 2009 Apr; 329(1):14-25. PubMed ID: 19168710
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease.
Pisetsky DS; Erlandsson-Harris H; Andersson U
Arthritis Res Ther; 2008; 10(3):209. PubMed ID: 18598385
[TBL] [Abstract][Full Text] [Related]
14. The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis.
Chen Y; Sun W; Gao R; Su Y; Umehara H; Dong L; Gong F
Rheumatology (Oxford); 2013 Oct; 52(10):1739-47. PubMed ID: 23584368
[TBL] [Abstract][Full Text] [Related]
15. Is HMGB1 an osteocyte alarmin?
Bidwell JP; Yang J; Robling AG
J Cell Biochem; 2008 Apr; 103(6):1671-80. PubMed ID: 17948903
[TBL] [Abstract][Full Text] [Related]
16. [Neutrophils in rheumatoid inflammation].
Biasi D; Carletto A; Caramaschi P; Bonella F; Bambara V; Pacor ML; Bambara LM
Recenti Prog Med; 2003 Jan; 94(1):25-30. PubMed ID: 12632997
[TBL] [Abstract][Full Text] [Related]
17. Contemporary concepts of inflammation, damage and repair in rheumatic diseases.
Luyten FP; Lories RJ; Verschueren P; de Vlam K; Westhovens R
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):829-48. PubMed ID: 16980209
[TBL] [Abstract][Full Text] [Related]
18. Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease.
Daans M; Lories RJ; Luyten FP
Arthritis Res Ther; 2008; 10(5):R115. PubMed ID: 18816401
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-33 - cytokine of dual function or novel alarmin?
Haraldsen G; Balogh J; Pollheimer J; Sponheim J; Küchler AM
Trends Immunol; 2009 May; 30(5):227-33. PubMed ID: 19359217
[TBL] [Abstract][Full Text] [Related]
20. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
